Investing in cannabis stocks is back in focus as regulatory progress and expanding medical use steadily lift demand. The ...

Q2 2026 Management View CEO Irwin Simon reported, "We delivered a strong second quarter marked by record results and a beat against analyst expectations in the face of strong headwinds. We recorded ...

In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related to rescheduling marijuana as a less-dangerous drug.

Recent regulatory developments have improved the landscape of the cannabis industry in the U.S. Canopy Growth and Aurora ...

The legal cannabis market is projected to reach $102.2 billion globally by 2030, growing at a sizzling 25.7% annual rate, according to a report by Grand View Research. This dramatic growth is expected ...

U.S. cannabis stocks appear to have completed their post-Executive Order pullback, says Beacon Securities analyst Russell ...

Financiers at New York event note the realities around federal rescheduling and local permitting A reality check around regulatory challenges facing the cannabis sector has taken hold among some of ...

Many cannabis stocks have experienced significant growth over the past six months. For instance, shares of Tilray Brands ...